Neuroleptic malignant syndrome (NMS): management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Neuroleptic malignant syndrome (NMS): management. Raised creatinine kinase (CK), Leucocytosis, Rhabdomyolysis. Fully referenced neurology checklist.
Investigations
- Raised creatinine kinase (CK)
- Leucocytosis
- Rhabdomyolysis
- Renal impairment
- Abnormal liver function
- Abnormal coagulation
Treatment of rigidity
Locked: subscribe to see this section.
Treatment of excessive dopaminergic block
Locked: subscribe to see this section.
Non-drug treatments
Locked: subscribe to see this section.
References
- Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth 2000; 85:129-135.
- Munhoz RP, Moscovich M, Araujo PD, Tieve HAG. Movement disorders emergencies: a review. Arq Neuropsiquiatr 2012; 70:453-461.
- Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164:871-876.
